<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01910272</url>
  </required_header>
  <id_info>
    <org_study_id>UCSD #120980</org_study_id>
    <nct_id>NCT01910272</nct_id>
  </id_info>
  <brief_title>Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures</brief_title>
  <acronym>BRAIN</acronym>
  <official_title>Brain Radiation Exposure and Attenuation During Invasive Cardiology Procedures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Invasive cardiac procedures involve procedural guidance with x-rays in the form of
      fluoroscopy. X-ray exposure poses a potential risk of acute and long-term complications to
      staff involved in these procedures. Lead shields are placed between the operators (on their
      left side) and the x-ray source to limit exposure. However as the operator requires direct
      access to the patient and x-ray scatter occurs, full protection is not possible. Lead gowns,
      thyroid collars, and leaded glasses are typically worn to protect the body, thyroid, and eyes
      respectively, but their thickness is limited by their relatively heavy weight. Nevertheless
      this leaves the brain exposed. Further, interest in the risk of brain cancer in invasive
      cardiologists has re-emerged after a recent report of left-sided brain cancer in primary
      operators of interventional cardiology procedures. Lead caps have been tested in the past but
      the relatively heavyweight of lead has limited wide-spread implementation. The cap typically
      worn during invasive procedures is lightweight, has no significant x-ray absorption
      properties, and is worn to help maintain a sterile environment. A novel, lead-free cap,
      composed mainly of barium sulfate and bismuth oxide, has been developed that has been shown
      to absorb x-rays while being significantly lighter than lead. The investigators propose using
      multiple x-ray detectors to test exposure differences between the primary and secondary
      operators, the left side and right side of the head, and absorption via a lead-free cap.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective study evaluating radiation exposure to operators of invasive
      cardiovascular procedures at the UCSD Medical Center in La Jolla. Primary and secondary
      operators of cardiac catheterization procedures using fluoroscopy guidance, including cardiac
      catheterization, coronary angiography, and interventional procedures will wear multiple
      dosimeters to evaluate levels of radiation exposure. The primary and secondary operators will
      wear six dosimeters on their heads; three outside the non-lead attenuating cap and three
      underneath the cap. Above and beneath the cap, the dosimeters will be on the left side, in
      the center, and on the right side of the head. The dosimeters will be worn for a target of at
      least 50 procedures for each operator. The primary operators will be closest to the
      procedural site and the fluoroscopy unit for the majority of the procedure, while the
      secondary operators will be to the right side of the primary operators during the procedures.
      The operators will maintain this designation while participating in the study. All operators
      will continue to wear the dosimeters issued by the catheterization laboratory as part of
      standard radiation monitoring.

      Each operator will be assigned six dosimeters, which will be secured within the cap at the
      time of assignment. The use of each cap and respective set of dosimeters will be recorded in
      a log book in the secure cardiac catheterization laboratory and associated with specific
      cardiac case numbers. Specific factors related to operator radiation exposure for each
      procedure will be recorded including: operator height, patient weight and BMI, dose area
      product (DAP), fluoroscopy time, length of procedure, type of procedure, access site, and
      complexity of procedure as determined by the attending physician. The operators will comment
      on the comfort of the cap using a semi-quantitative scale and the levels of exposure will be
      measured from the dosimeters. The operators will also be asked to compare and contrast the
      study cap with any other attenuating or non-attenuating cap that has been previously worn. At
      the conclusion of the study, statistical analysis will be performed to determine the
      differential levels of exposure between the primary and secondary operators, between
      different sides of the head, and the attenuation ability of the XPF cap. The dosimeters on
      the outside of the cap will serve as the control in evaluating the attenuating ability of the
      cap compared to the corresponding dosimeters on the inside. Each dosimeter location on the
      outside of the cap will be compared to the other locations for both the outside and the
      inside sets. And finally, the exposure measurements will be compared between the primary and
      secondary operators for each dosimeter location. The specific factors listed above that
      affect operator exposure will be taken into account as well.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differential radiation exposure from corresponding locations on the outside and inside of the non-lead attenuating cap.</measure>
    <time_frame>Radiation exposure has been ongoing and will be assessed upon dosimeter measurement in within 1 month by an independent radiation monitoring service.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differential radiation exposure between the left and right sides of the heads of invasive cardiology operators.</measure>
    <time_frame>Dosimeters measurement to be read/reported within one month.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Differential radiation exposure between primary and secondary operators of invasive cardiology procedures.</measure>
    <time_frame>Dosimeters measurement to be read/reported within one month.</time_frame>
  </other_outcome>
  <enrollment type="Actual">11</enrollment>
  <condition>Radiation Effects</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>All subjects are wearing the non-lead attenuation cap (BLOXR)</intervention_name>
    <description>The cap is worn by all subjects with dosimeters secured both inside and outside the cap.</description>
    <other_name>Attenuating cap, BLOXR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We plan to enroll up to 12 invasive cardiologists routinely performing cardiac
        catheterization procedures at the UCSD Medical Center, La Jolla campus. We plan to monitor
        radiation exposure in at least 50 cases for each operator.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Routinely performing cardiac catheterization procedures as the primary or secondary
             operators

        Exclusion Criteria:

          -  Cases with emergent indications including STEMI will be excluded

          -  Cases consisting of solely right heart catheterization will be excluded
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ehtisham Mahmud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego, Sulpizio Cardiovascular Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://bloxr.com/attenuating-caps/attenuating-caps-heatlhcare.html</url>
    <description>link to company website regarding the attenuating cap</description>
  </link>
  <reference>
    <citation>Andreassi MG, Cioppa A, Botto N, Joksic G, Manfredi S, Federici C, Ostojic M, Rubino P, Picano E. Somatic DNA damage in interventional cardiologists: a case-control study. FASEB J. 2005 Jun;19(8):998-9. Epub 2005 Mar 31.</citation>
    <PMID>15802491</PMID>
  </reference>
  <reference>
    <citation>Andreassi MG, Foffa I, Manfredi S, Botto N, Cioppa A, Picano E. Genetic polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists. Mutat Res. 2009 Jun 18;666(1-2):57-63. doi: 10.1016/j.mrfmmm.2009.04.003. Epub 2009 Apr 22.</citation>
    <PMID>19393248</PMID>
  </reference>
  <reference>
    <citation>Bernardi G, Padovani R, Morocutti G, Va√±o E, Malisan MR, Rinuncini M, Spedicato L, Fioretti PM. Clinical and technical determinants of the complexity of percutaneous transluminal coronary angioplasty procedures: analysis in relation to radiation exposure parameters. Catheter Cardiovasc Interv. 2000 Sep;51(1):1-9; discussion 10.</citation>
    <PMID>10973008</PMID>
  </reference>
  <reference>
    <citation>Goni H, Papadopoulou D, Yakoumakis E, Stratigis N, Benos J, Siriopoulou V, Makri T, Georgiou E. Investigation of occupational radiation exposure during interventional cardiac catheterisations performed via radial artery. Radiat Prot Dosimetry. 2005;117(1-3):107-10. Epub 2006 Feb 3.</citation>
    <PMID>16461487</PMID>
  </reference>
  <reference>
    <citation>Kim KP, Miller DL, Balter S, Kleinerman RA, Linet MS, Kwon D, Simon SL. Occupational radiation doses to operators performing cardiac catheterization procedures. Health Phys. 2008 Mar;94(3):211-27. doi: 10.1097/01.HP.0000290614.76386.35. Review.</citation>
    <PMID>18301095</PMID>
  </reference>
  <reference>
    <citation>Kuon E, Birkel J, Schmitt M, Dahm JB. Radiation exposure benefit of a lead cap in invasive cardiology. Heart. 2003 Oct;89(10):1205-10.</citation>
    <PMID>12975420</PMID>
  </reference>
  <reference>
    <citation>Roguin A, Goldstein J, Bar O. Brain tumours among interventional cardiologists: a cause for alarm? Report of four new cases from two cities and a review of the literature. EuroIntervention. 2012 Jan;7(9):1081-6. doi: 10.4244/EIJV7I9A172. Review.</citation>
    <PMID>22207231</PMID>
  </reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2013</study_first_submitted>
  <study_first_submitted_qc>July 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2013</study_first_posted>
  <last_update_submitted>July 26, 2013</last_update_submitted>
  <last_update_submitted_qc>July 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Ryan Reeves</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Radiation attenuation</keyword>
  <keyword>Fluoroscopy</keyword>
  <keyword>Invasive cardiac procedures</keyword>
  <keyword>Cardiac Catheterization</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

